FluoroPharma Medical Operating Income 2010-2016 | FPMI
FluoroPharma Medical operating income from 2010 to 2016. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
| FluoroPharma Medical Annual Operating Income (Millions of US $) |
|
|---|---|
| 2016 | $-2 |
| 2015 | $-3 |
| 2014 | $-5 |
| 2013 | $-4 |
| 2012 | $-4 |
| 2011 | $-3 |
| 2010 | $-1 |
| 2009 | $-0 |
| FluoroPharma Medical Quarterly Operating Income (Millions of US $) |
|
|---|---|
| 2016-12-31 | $-1 |
| 2016-09-30 | $-0 |
| 2016-06-30 | $-1 |
| 2016-03-31 | $-1 |
| 2015-12-31 | $-1 |
| 2015-09-30 | $-1 |
| 2015-06-30 | $-1 |
| 2015-03-31 | $-1 |
| 2014-12-31 | $-1 |
| 2014-09-30 | $-1 |
| 2014-06-30 | $-1 |
| 2014-03-31 | $-1 |
| 2013-12-31 | $-1 |
| 2013-09-30 | $-1 |
| 2013-06-30 | $-1 |
| 2013-03-31 | $-1 |
| 2012-12-31 | $-1 |
| 2012-09-30 | $-1 |
| 2012-06-30 | $-1 |
| 2012-03-31 | $-1 |
| 2011-12-31 | $-1 |
| 2011-09-30 | $-0 |
| 2011-06-30 | $-2 |
| 2011-03-31 | $-0 |
| 2010-12-31 | $-1 |
| 2010-09-30 | $-0 |
| 2010-06-30 | $-0 |
| 2010-03-31 | $-0 |
| 2009-12-31 | $-0 |
| 2009-09-30 | $-0 |
| 2009-06-30 | $-0 |
| 2009-03-31 | $-0 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.000B | $0.000B |
| FluoroPharma Medical, Inc. is engaged in the discovery, development and commercialization of proprietary medical diagnostic imaging products. The company's initial focus is the development of positron emission tomography imaging agents for the detection and assessment of acute and chronic forms of coronary artery disease. Other products in development include agents for detection of inflamed atherosclerotic plaque in peripheral arteries, amyloid plaque in Alzheimer's disease and agents for detection of certain types of cancer. FluoroPharma Medical, Inc. is headquartered in Boston, Massachusetts. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $180.365B | 23.62 |
| Stryker (SYK) | United States | $131.420B | 31.48 |
| Boston Scientific (BSX) | United States | $112.614B | 35.87 |
| Medtronic (MDT) | Ireland | $107.607B | 15.56 |
| EssilorLuxottica (ESLOY) | France | $98.278B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $40.027B | 0.00 |
| Haleon (HLN) | United Kingdom | $38.310B | 27.97 |
| ResMed (RMD) | United States | $31.105B | 29.20 |
| Terumo (TRUMY) | Japan | $24.507B | 34.61 |
| Koninklijke Philips (PHG) | Netherlands | $23.286B | 18.48 |
| Zimmer Biomet Holdings (ZBH) | United States | $22.052B | 14.09 |
| Baxter (BAX) | United States | $17.214B | 12.24 |
| Insulet (PODD) | United States | $14.039B | 62.25 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $11.065B | 0.00 |
| Demant (WILYY) | Denmark | $10.984B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $8.051B | 26.33 |
| BellRing Brands (BRBR) | United States | $7.200B | 33.87 |
| Lantheus Holdings (LNTH) | United States | $5.494B | 13.69 |
| GN Store Nord (GNNDY) | Denmark | $4.887B | 27.44 |
| Haemonetics (HAE) | United States | $4.314B | 21.27 |
| Neogen (NEOG) | United States | $3.685B | 35.44 |
| Perrigo (PRGO) | Ireland | $3.660B | 11.10 |
| Prestige Consumer Healthcare (PBH) | United States | $3.207B | 15.26 |
| Envista Holdings (NVST) | United States | $3.037B | 12.53 |
| ICU Medical (ICUI) | United States | $2.768B | 24.43 |
| TG Therapeutics (TGTX) | United States | $2.558B | 71.96 |
| Agios Pharmaceuticals (AGIO) | United States | $2.504B | 0.00 |
| QuidelOrtho (QDEL) | United States | $2.441B | 13.55 |
| Green Thumb Industries (GTBIF) | United States | $2.426B | 47.50 |
| Maravai LifeSciences Holdings (MRVI) | United States | $1.894B | 0.00 |
| LeMaitre Vascular (LMAT) | United States | $1.798B | 52.69 |
| Warby Parker (WRBY) | United States | $1.607B | 0.00 |
| InMode (INMD) | Israel | $1.532B | 8.14 |
| AdaptHealth (AHCO) | United States | $1.509B | 11.22 |
| Owens & Minor (OMI) | United States | $1.278B | 11.13 |
| Verano Holdings (VRNOF) | United States | $1.091B | 0.00 |
| National Vision Holdings (EYE) | United States | $1.055B | 33.58 |
| AtriCure (ATRC) | United States | $0.988B | 0.00 |
| BioLife Solutions (BLFS) | United States | $0.931B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.791B | 0.00 |
| Evolus (EOLS) | United States | $0.709B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.697B | 14.85 |
| PetIQ (PETQ) | United States | $0.642B | 20.75 |
| VAREX IMAGING (VREX) | United States | $0.616B | 14.48 |
| Surmodics (SRDX) | United States | $0.598B | 37.46 |
| Canopy Growth (CGC) | Canada | $0.552B | 0.00 |
| Quanterix (QTRX) | United States | $0.510B | 0.00 |
| Valneva SE (VALN) | France | $0.505B | 0.00 |
| ZimVie (ZIMV) | United States | $0.429B | 36.53 |
| Jin Medical (ZJYL) | China | $0.411B | 0.00 |
| Biote (BTMD) | United States | $0.396B | 9.11 |
| TerrAscend (TSNDF) | Canada | $0.382B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.327B | 10.52 |
| Cerus (CERS) | United States | $0.322B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.313B | 0.00 |
| Zynex (ZYXI) | United States | $0.286B | 39.09 |
| MacroGenics (MGNX) | United States | $0.280B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.272B | 26.92 |
| Sanara MedTech (SMTI) | United States | $0.259B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.236B | 14.84 |
| Omeros (OMER) | United States | $0.235B | 0.00 |
| Ayr Wellness (AYRWF) | United States | $0.209B | 0.00 |
| High Tide (HITI) | Canada | $0.198B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.164B | 0.00 |
| Organigram Holdings (OGI) | Canada | $0.158B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.157B | 0.00 |
| Eagleford Energy (GRUSF) | United States | $0.144B | 68.97 |
| Quipt Home Medical (QIPT) | United States | $0.139B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.137B | 19.53 |
| Veru (VERU) | United States | $0.119B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.115B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.109B | 0.00 |
| InterCure (INCR) | Israel | $0.108B | 18.15 |
| Brainsway (BWAY) | Israel | $0.102B | 0.00 |
| Fonar (FONR) | United States | $0.095B | 9.65 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.091B | 0.00 |
| Chimerix (CMRX) | United States | $0.079B | 0.00 |
| MariMed (MRMD) | United States | $0.073B | 0.00 |
| Safety Shot (SHOT) | United States | $0.061B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.059B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.056B | 0.00 |
| Zevia PBC (ZVIA) | United States | $0.055B | 0.00 |
| Apyx Medical (APYX) | United States | $0.050B | 0.00 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.050B | 3.26 |
| Bright Green (BGXX) | United States | $0.050B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.046B | 0.00 |
| United-Guardian (UG) | United States | $0.041B | 15.00 |
| Modular Medical (MODD) | United States | $0.036B | 0.00 |
| Exagen (XGN) | United States | $0.034B | 0.00 |
| ImmuCell (ICCC) | United States | $0.033B | 0.00 |
| Nephros (NEPH) | United States | $0.022B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.021B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.018B | 0.00 |
| Agape ATP (ATPC) | $0.018B | 0.00 | |
| Flora Growth (FLGC) | United States | $0.014B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.013B | 0.00 |
| GUARDION HEALTH (GHSI) | United States | $0.013B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.010B | 0.00 |
| FSD PHARMA (HUGE) | Canada | $0.009B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.007B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.006B | 0.00 |
| Leafly Holdings (LFLY) | United States | $0.006B | 0.00 |
| Sharps Technology (STSS) | United States | $0.005B | 0.00 |
| Senestech (SNES) | United States | $0.003B | 0.00 |
| Lucy Scientific Discovery (LSDI) | Canada | $0.001B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.001B | 0.00 |
| Smart For Life (SMFL) | United States | $0.000B | 0.00 |
| Bruush Oral Care (BRSH) | $0.000B | 0.00 | |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |